
The addition of Hylan G-F 20 injections to standard care beneficial for knee OA

The addition of Hylan G-F 20 injections to standard care beneficial for knee OA
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results
Osteoarthritis Cartilage. 2002 Jul;10(7):506-17Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
255 patients, over the age of 40, with a diagnosis of knee osteoarthritis were randomized to receive either appropriate care alone or 3 intra-articular injections of hylan G-F 20 at 1-week intervals in addition to appropriate care. The purpose of this randomized controlled trial was to determine the clinical effectiveness of hylan G-F 20 injections in terms of disease-specific outcomes and health-...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.